2543 Weekly cabazitaxel in 'unfit' metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. CABASEM-SOGUG phase II trial

التفاصيل البيبلوغرافية
العنوان: 2543 Weekly cabazitaxel in 'unfit' metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. CABASEM-SOGUG phase II trial
المؤلفون: Cristina Caballero, M.J. Juan, Begoña Mellado, Montserrat Domenech, Luis León, E.M. Fernandez Parra, O. Fernandez Calvo, Daniel Castellano, S. Hernando, Urbano Anido, Miguel Angel Climent, L. Munielo, Marc Campayo, B. Perez Valderrama, J. A. Arranz, M. Ochoa, P. Estevez
المصدر: European Journal of Cancer. 51:S490
بيانات النشر: Elsevier BV, 2015.
سنة النشر: 2015
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Castration resistant, medicine.disease, Prostate cancer, Docetaxel, Cabazitaxel, Internal medicine, Medicine, business, medicine.drug
تدمد: 0959-8049
DOI: 10.1016/s0959-8049(16)31362-4
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f2f842e8c37a85e37e5773c13d1410a0
https://doi.org/10.1016/s0959-8049(16)31362-4
Rights: CLOSED
رقم الانضمام: edsair.doi...........f2f842e8c37a85e37e5773c13d1410a0
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09598049
DOI:10.1016/s0959-8049(16)31362-4